18 Hrs
Source:
الاتحاد
M42 Presents Early Detection Techniques at Future of Health Summit
The article discusses the participation of the Diagnostic Group in "M42" during the "Future of Health Summit 2026" in Abu Dhabi. It highlighted early diagnosis techniques for Alzheimer's disease through blood tests that can detect disease indicators approximately 10 to 15 years before symptoms appear, in collaboration with Cleveland Clinic Abu Dhabi. The group's CEO, Dr. Leila Abdul Warith, emphasized that technological advancements have enabled early detection of biomarkers, with new medications for treatment now approved by the U.S. Food and Drug Administration (FDA). The article underlines the importance of early diagnosis in improving treatment planning and delaying disease progression.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)